Manufacturer Challenges to Contract Pharmacy Arrangements
August 11th, 2020
This is an in-depth review on the challenges 340B entities & contract pharmacies are facing from recent drug manufacturer notices – Merck, Eli Lilly & Sanofi as well as Executive Orders.
Peggy Tighe, Principal, Powers Law
Bill von Oehsen, Principal, Powers Law
Share your concerns,
we’ll deliver a solution.
Contact our team today.